Most Recent
Mastercard risked losing half its revenue from retail interchange fees as a result of the Reserve Bank's least-cost routing initiative, and struck deals with top retailers to defend its core business, a court was told Wednesday.
EnergyAustralia has lost its appeal of a finding that it's on the hook for portable long service leave for maintenance workers at its Yallourn power station because its significant maintenance activities mean it's 'in the construction industry', a ruling that could affect energy, rail and telecommunications firms.
Construction PRO
Private toll road operator Atlas Arteria has urged shareholders to reject a $7 billion hostile takeover offer from IFM Investors that allegedly undervalues the company.
A trial judge has heard that Mastercard's top Australian executives discussed stripping Woolworths of strategic merchant status if the supermarket giant routed customer transactions through the cheaper EFTPOS network.
A global settlement may now be within reach in a class action brought by Navy technicians over training contracts after a larger number of same group members' claims have been assessed, a court has heard.
A judge has ruled that the initial trial in a union’s underpayments class action against McDonald’s will deal with a claim that it knowingly breached the Fair Work Act and that there was a systemic pattern of conduct.
The Full Court has tossed a former Neometals employee's appeal of his failed whistleblower case, finding the company did not believe he had made a protected disclosure when making him redundant despite the company conceding that the was "somebody who frequently raised issues".
ANZ's New Zealand unit says it may be on the hook for $102.5 million (NZ$125 million) after losing a class action alleging it failed to repay fees and interest wrongly charged to customers who took out home or personal loans.
Two Sydney University academics facing discrimination suits over alleged antisemitic statements have argued proposed amendments risk blowing up the cases into "another royal commission".
Pharmacor has accused AstraZeneca of launching a royal commission into emails with its lawyers as AstraZeneca opposes the generic drug maker's bid to amend its pleading in a patent case over diabetes drug Forxiga.